Kairos Pharma Ltd. (KAPA)
AMEX: KAPA
· Real-Time Price · USD
1.19
-0.05 (-4.03%)
At close: Aug 15, 2025, 3:59 PM
1.22
2.68%
After-hours: Aug 15, 2025, 07:56 PM EDT
Kairos Pharma Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 |
PE Ratio | -2.15 | -2.94 | -5.33 | -4.09 | -32.99 | -21.25 | -6.09 | -23.37 | -28.46 | -46.01 | -34.27 | -28.48 | -17.19 | -28.15 |
PEG Ratio | -0.55 | -0.26 | 0.21 | -0.01 | 0.93 | 0.29 | -0.02 | -1.07 | -0.46 | 1.78 | 2.06 | 0.72 | -0.27 | n/a |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 2.04 | 2.08 | 4.37 | 5.14 | -37.73 | -29.88 | -13.1 | -62.98 | -17.21 | -20.28 | -22.79 | n/a | n/a | n/a |
P/FCF Ratio | -15.16 | -20.81 | -11.58 | -8.48 | -198.74 | 762.81 | 412.53 | 320.45 | -395.12 | -3.36K | -389.43 | -512.55 | -315.06 | -178.82 |
P/OCF Ratio | -15.16 | -20.81 | -11.58 | -8.48 | -198.74 | 762.81 | 412.53 | 320.45 | -395.12 | -3.36K | -389.43 | -512.55 | -315.06 | -178.82 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | n/a | n/a | n/a | 0.04 | -0.88 | -0.72 | -0.31 | -1.33 | -0.39 | -0.45 | -0.5 | n/a | n/a | n/a |
Quick Ratio | 7.16 | 7.52 | 4.20 | 2.84 | 0.02 | 0.02 | 0.04 | 0.08 | 0.13 | 0.22 | 0.27 | n/a | n/a | n/a |
Current Ratio | 7.16 | 7.52 | 4.20 | 2.84 | 0.02 | 0.02 | 0.04 | 0.08 | 0.13 | 0.22 | 0.27 | n/a | n/a | n/a |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | -10.87 | -0.58 | -7.16 | -7.97 | -37.55 | -11.48 | -8.83 | -6.3 | n/a | -1.13 | -0.45 | -1.67 |
Return on Equity | -0.24 | -0.18 | -0.21 | -0.31 | 0.29 | 0.35 | 0.54 | 0.67 | 0.15 | 0.11 | 0.17 | n/a | n/a | n/a |
Return on Assets | -0.21 | -0.16 | -0.17 | -0.21 | -0.25 | -0.33 | -1.16 | -0.33 | -0.24 | -0.15 | -0.19 | n/a | n/a | n/a |
Return on Invested Capital | -0.24 | -0.18 | -0.3 | -0.11 | 0.28 | 0.16 | 0.76 | 0.63 | 0.22 | 0.17 | 0.30 | n/a | n/a | n/a |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |